Fine Foods & Pharmaceuticals Ntm Logo

Fine Foods & Pharmaceuticals Ntm

ISIN: IT0005215329 | Ticker: FF | LEI: 8156009111DEE8553765
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Italy

About Fine Foods & Pharmaceuticals Ntm

Company Description

Fine Foods is active in the contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries and in the cosmetics, medical aid and biocide sectors through its Euro Cosmetic and Pharmatek-PMC production facilities.

Year founded

1984

Served area

Worldwide

Headcount

750

Headquarters

Via Berlino 39, 24040 Zingonia-Verdellino – Italy

Financial statements

Download as Excel
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Assets N/A 302,810,211.00 299,820,309.00
Noncurrent Assets N/A 131,259,960.00 135,147,200.00
Property Plant And Equipment N/A 102,886,510.00 104,162,050.00
Goodwill N/A 15,907,954.00 15,907,954.00
Intangible Assets Other Than Goodwill N/A 2,337,675.00 1,780,551.00
Deferred Tax Assets N/A 3,482,100.00 7,312,662.00
Other Noncurrent Nonfinancial Assets N/A 237,333.00 820,871.00
Current Assets N/A 171,550,251.00 164,673,109.00
Inventories N/A 35,050,484.00 40,422,499.00
Current Trade Receivables N/A 29,433,391.00 39,347,321.00
Current Tax Assets Current N/A 2,421,853.00 2,268,044.00
Cash and cash equivalents 3,342,518.00 17,118,957.00 10,232,262.00
Other Current Assets N/A 9,554,455.00 5,890,398.00
Equity And Liabilities N/A 302,810,211.00 299,820,309.00
Equity 141,008,161.00 147,217,991.00 133,289,763.00
Issued Capital N/A 22,770,445.00 22,770,445.00
Retained Earnings N/A 0.00 22,610.00
Other Reserves N/A 132,615,098.00 126,461,456.00
Noncurrent Liabilities N/A 45,885,684.00 82,496,684.00
Noncurrent Provisions For Employee Benefits N/A 3,010,691.00 2,419,013.00
Other Longterm Provisions N/A 35,489.00 41,105.00
Deferred Tax Liabilities N/A 1,081,159.00 240,553.00
Longterm Borrowings N/A 35,298,177.00 77,573,797.00
Noncurrent Portion Of Noncurrent Bonds Issued N/A 3,322,876.00 0.00
Current Liabilities N/A 109,706,537.00 84,033,862.00
Trade And Other Current Payables To Trade Suppliers N/A 32,532,117.00 33,450,468.00
Current Tax Liabilities Current N/A 5,536.00 0.00
Other Current Financial Liabilities N/A 8,096,854.00 10,018,421.00
Current Bonds Issued And Current Portion Of Noncurrent Bonds Issued N/A 3,310,176.00 3,323,051.00
Line item in (eur) 01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 195,244,559.00 208,319,727.00
Revenue From Contracts With Customers 194,849,556.00 206,852,576.00
Services Expense 20,839,099.00 25,190,520.00
Employee Benefits Expense 34,823,128.00 38,300,569.00
Depreciation And Amortisation Expense 14,527,508.00 16,420,419.00
Profit Loss From Operating Activities 5,034,230.00 -1,011,413.00
Finance Income 36,202.00 59,214.00
Finance Costs 763,305.00 2,246,228.00
Profit Loss Before Tax -4,590,253.00 -14,198,912.00
Income Tax Expense Continuing Operations -3,163,501.00 -4,697,768.00
Profit (loss) -1,426,751.00 -9,501,145.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -1,426,751.00 -9,501,145.00
Adjustments For Income Tax Expense N/A -1,301,460.00 68,715.00
Adjustments For Finance Costs N/A 745,520.00 2,179,317.00
Adjustments For Decrease Increase In Inventories N/A -9,992,403.00 -5,944,094.00
Adjustments For Increase Decrease In Trade Account Payable N/A 1,995,703.00 918,351.00
Adjustments For Provisions N/A 0.00 39,000.00
Other Adjustments For Noncash Items N/A 1,058,445.00 0.00
Interest Paid Classified As Operating Activities N/A -712,535.00 -2,156,964.00
Cash Flows From Used In Operating Activities N/A -5,826,715.00 3,688,374.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 18,353,280.00 0.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 239,717.00 209,017.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 14,849,438.00 15,026,843.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 1,070,725.00 957,395.00
Cash Flows From Used In Investing Activities N/A -36,347,779.00 -15,314,586.00
Proceeds From Borrowings Classified As Financing Activities N/A 90,066,513.00 72,744,341.00
Repayments Of Borrowings Classified As Financing Activities N/A 12,313,170.00 62,175,238.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 520,326.00 1,091,921.00
Dividends Paid Classified As Financing Activities N/A 3,205,727.00 3,866,869.00
Other Inflows Outflows Of Cash Classified As Financing Activities N/A -11,064,496.00 0.00
Cash Flows From Used In Financing Activities N/A 55,950,934.00 4,739,517.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 13,776,440.00 -6,886,695.00
Cash and cash equivalents 3,342,518.00 17,118,957.00 10,232,262.00

Please note that some sums might not add up.

Filings & Publications

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

IT0005215329

LEI

8156009111DEE8553765

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.